Biomarin Pharmaceutical Inc (NAS:BMRN)
$ 67.2898 0.2198 (0.33%) Market Cap: 12.82 Bil Enterprise Value: 12.46 Bil PE Ratio: 40.29 PB Ratio: 2.37 GF Score: 69/100

Biomarin Pharmaceutical Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2020 / 03:40PM GMT
Release Date Price: $71.87 (-3.52%)
Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. Good morning, everyone. It is still good morning, at least in the East Coast. My name is Mohit Bansal. I'm one of the analysts here at Citi. And I'm happy to have today the BioMarin management team. We have J.J. Bienaimé, the Chairman and CEO of the company; Hank Fuchs, the President and Worldwide -- President of Worldwide R&D at BioMarin. You also have Brian Mueller, the CFO of the company. So we are happy to have the team today. Thank you for joining us today.

Jean;Jacques BienaimÃ;BioMarin Pharmaceutical Inc.;Chairman;CEO

©,-&

Thank you, Mohit.

Henry J. Fuchs
BioMarin Pharmaceutical Inc. - President of Worldwide Research & Development

Thank you for having us.

Jean;Jacques BienaimÃ;BioMarin Pharmaceutical Inc.;Chairman;CEO

©,-&

So do you want me to start with a few

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot